Pfizer plans offering to pare Zoetis stake
14 hours, 56 minutes ago
Pfizer said several conditions must be met for the completion of the exchange offer, including having at least 160.4 million shares of Zoetis common stock distributed in exchange for Pfizer shares.
Pfizer's Viagra site won't stop counterfeiters
13 days ago
Pfizer Inc., the drug's producer, now has a site for you: its own Viagra.com, where you can get the blockbuster impotence fighter without wondering what shady source you're dealing with.
Bashful? Buy the little blue pill online
16 days ago
In a first for the drug industry, Pfizer Inc. told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra directly to patients on its website.
News Summary: Pfizer 1Q profit up, forecast down
22 days ago
THE REACTION: Between the weak results and Pfizer lowering its profit and revenue forecast for the year, investors drove down shares by an unusually steep 4.5 percent.
Stocks edge lower; Pfizer weighs down the Dow
22 days ago
Pfizer was among the biggest decliners in the Dow after the drugmaker's results fell short of what Wall Street analysts were expecting.
Pfizer Q1 profit up, but drugmaker cuts outlook
22 days ago
Results fell short of Wall Street expectations, and Pfizer lowered its 2013 profit forecast by 6 cents to $2.14 to $2.24 per share.
Stocks drift mostly higher; Pfizer weighs on Dow
22 days ago
Stocks are drifting mostly higher on Wall Street, but poor results from Pfizer are holding down the Dow Jones industrial average.
Stocks flip between gains and losses
22 days ago
Weak earnings from Pfizer and other companies held back major market indexes on Tuesday, as the Standard & Poor's 500 flipped between slight gains and losses.
FDA adds heart risk warning to popular antibiotic
71 days ago
The Food and Drug Administration is warning doctors and patients that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients.
News Summary: Pfizer painkiller patent extended
78 days ago
PATENT WIN: Drugmaker Pfizer gets an 18-month extension on a key patent for its blockbuster anti-inflammatory painkiller, as the federal government grants a new patent for Celebrex.